Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Thursday 26 March, 2020

UBS O'Connor Limited

Allergan plc

RNS Number : 7435H
UBS O'Connor Limited
26 March 2020
 

Ap19

 

 

FORM   8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.  KEY   INFORMATION

 

Nameofpersondealing (Note 1)

UBS O'Connor [i]

Companydealtin

Allergan plc

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 2)

 US$0.0001 Ordinary Shares

of dealing

25-March-2020

 

2.  INTERESTS AND SHORT POSITIONS

 

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note   3)

 

Long

 

 

 

(1)Relevantsecurities

 

 

Derivatives than options)

5,800,621  1.76

 

(3)Optionsandagreementstopurchase/sell

 

 

Total

5,800,621  1.76

 

             

 

(b)  Interests and short positions in relevant securities of the company, other than the class dealt in  (Note   3)

Classofrelevantsecurity:

Long

Short

 

 

 

(1)Relevantsecurities

 

 

 

Derivatives than options)

 

 

 

(3)Optionsandagreementstopurchase/sell

 

 

Total

 

 

             

 

Ap20

 

 

1.  DEALINGS  (Note   4)

 

(a)  Purchases and sales

 

 

Purchase/sale

 

Numberofrelevantsecurities

 

Priceperunit 5)

 

 

 

 

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

CFD

Natureoftransaction

6)

Numberofrelevantsecurities

7)

Priceperunit

5)

CFD

Purchase

50,000

 

 

169.9285  USD

 

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing, selling, purchasing or varying

 

Productname,

e.g. call option

Writing, selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates (Note 7)

Exercise price

Type, e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit (Note 5)

 

 

 

 

 

 

 

 

 

(ii)  Exercising

 

Productname,

call option

Numberofsecurities

Exercisepriceper unit (Note 5)

 

 

 

 

 

(c)  Other dealings (including transactions in respect of new securities) (Note 4)

 

of transaction

8)

per unit

 

 

 

 

Ap21

 

2.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any 
relevant securities to which any derivative referred to on this form is referenced. If none,
this should be stated.

 

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached?  (Note   9)   NO

 

Dateofdisclosure

26-March-2020

Contact name

James Mortimer

Telephone number

0207 901 5828

If aconnectedEFM,nameofofferee/offerorwithwhichconnected

 

If aconnectedEFM,statenatureofconnection (Note 10)

 

 

 

[i] This report is on behalf of the following entities

· UBS O'Connor Limited

· UBS O'Connor LLC

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEKKABQBBKDNNB

a d v e r t i s e m e n t